Is a Correction Looming Ahead for ProPhase Labs Inc. (PRPH) – News Heater
Home  »  Trending   »  Is a Correction Looming Ahead for ProPhase Labs In...

Is a Correction Looming Ahead for ProPhase Labs Inc. (PRPH)

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

ProPhase Labs Inc. (NASDAQ:PRPH) went up by 5.87% from its latest closing price compared to the recent 1-year high of $15.28. The company’s stock price has collected 12.47% of gains in the last five trading sessions. Press Release reported 14 hours ago that ProPhase Labs Diversifies with Formation of Genomics and Global Healthcare Subsidiaries

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Is It Worth Investing in ProPhase Labs Inc. (NASDAQ :PRPH) Right Now?

Plus, the 36-month beta value for PRPH is at -0.17. Opinions of the stock are interesting as 2 analysts out of 2 who provided ratings for ProPhase Labs Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”


5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored



The average price from analysts is $22.50. PRPH currently public float of 12.44M and currently shorts hold a 1.74% ratio of that float. Today, the average trading volume of PRPH was 278.00K shares.

PRPH’s Market Performance

PRPH stocks went up by 12.47% for the week, with a monthly jump of 5.51% and a quarterly performance of -20.19%, while its annual performance rate touched 278.47%. The volatility ratio for the week stands at 11.01% while the volatility levels for the past 30 days are set at 8.16% for ProPhase Labs Inc.. The simple moving average for the period of the last 20 days is 2.87% for PRPH stocks with a simple moving average of -20.25% for the last 200 days.

Analysts’ Opinion of PRPH

Many brokerage firms have already submitted their reports for PRPH stocks, with Dawson James repeating the rating for PRPH by listing it as a “Buy.” The predicted price for PRPH in the upcoming period, according to Dawson James is $25 based on the research report published on January 20th of the current year 2021.

PRPH Trading at 4.85% from the 50-Day Moving Average

After a stumble in the market that brought PRPH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -63.43% of loss for the given period.

Volatility was left at 8.16%, however, over the last 30 days, the volatility rate increased by 11.01%, as shares surge +3.71% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -10.85% lower at present.

During the last 5 trading sessions, PRPH rose by +12.47%, which changed the moving average for the period of 200-days by +94.77% in comparison to the 20-day moving average, which settled at $5.56. In addition, ProPhase Labs Inc. saw -36.10% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at PRPH starting from Karkus Ted William, who purchase 33,943 shares at the price of $5.07 back on Jun 03. After this action, Karkus Ted William now owns 2,333,471 shares of ProPhase Labs Inc., valued at $171,921 using the latest closing price.

GLECKEL LOUIS MD, the Director of ProPhase Labs Inc., purchase 50,000 shares at $2.75 during a trade that took place back on Aug 13, which means that GLECKEL LOUIS MD is holding 273,840 shares at $137,500 based on the most recent closing price.

Stock Fundamentals for PRPH

Current profitability levels for the company are sitting at:

  • -27.46 for the present operating margin
  • +31.73 for the gross margin

The net margin for ProPhase Labs Inc. stands at -16.03. The total capital return value is set at -21.83, while invested capital returns managed to touch -12.86. Equity return is now at value -1.20, with -0.70 for asset returns.

Based on ProPhase Labs Inc. (PRPH), the company’s capital structure generated 139.47 points at debt to equity in total, while total debt to capital is 58.24. Total debt to assets is 46.88, with long-term debt to equity ratio resting at 136.35. Finally, the long-term debt to capital ratio is 56.94.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

When we switch over and look at the enterprise to sales, we see a ratio of 7.77, with the company’s debt to enterprise value settled at 0.13. The receivables turnover for the company is 2.91 and the total asset turnover is 0.66. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.52.

Sign up for our FREE Newsletter and get:

Leave a Comment

Your email address will not be published. Required fields are marked *

Sign up for our FREE Newsletter and get:

A Lesson to Learn: 2U Inc. (TWOU)

2U Inc. (NASDAQ:TWOU) went up by 3.89% from its latest closing price compared to the recent 1-year high of $59.74. The company’s stock price has

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.